findmyKOL
Clinical trialNCT02796651CompletedPhase 2Interventional

Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

SponsorAstraZenecaEnrollment132Chronic Obstructive Pulmonary Disease - COPD
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mark H. Gotfried, MD

    1112 East McDowell Road, Phoenix, AZ 85006, United States.

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Research Site

    Glendale, Arizona, United States

  • Research Site

    Phoenix, Arizona, United States

  • Research Site

    Tempe, Arizona, United States

  • Research Site

    Celebration, Florida, United States

  • Research Site

    Clearwater, Florida, United States

  • Research Site

    DeLand, Florida, United States

  • Research Site

    Orlando, Florida, United States

  • Research Site

    Lawrenceville, Georgia, United States

  • Research Site

    St Louis, Missouri, United States

  • Research Site

    Las Vegas, Nevada, United States

  • Research Site

    Charlotte, North Carolina, United States

  • Research Site

    Gastonia, North Carolina, United States

  • Research Site

    Medford, Oregon, United States

  • Research Site

    Portland, Oregon, United States

  • Research Site

    Easley, South Carolina, United States

  • Research Site

    Greenville, South Carolina, United States

  • Research Site

    Rock Hill, South Carolina, United States

  • Research Site

    Spartanburg, South Carolina, United States

  • Research Site

    Boerne, Texas, United States

  • Research Site

    Killeen, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
7 Dec 2016
Completion
7 Dec 2016
Last update posted
7 Feb 2018
Registered enrollment
132
Registry id
NCT02796651

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.